{
"info": {
"nct_id": "NCT00320073",
"official_title": "A Two Arm Phase I Dose Escalation Trial of Vinflunine With Erlotinib or Pemetrexed in Refractory Solid Tumors",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed solid tumors\n\n * Advanced/unresectable or metastatic disease\n* Refractory to standard therapy OR no standard therapy exists\n* No lymphoma\n* Measurable or evaluable disease\n\n * Measurable disease is defined as at least one target lesion measuring ≥ 20 mm by conventional techniques or ≥ 10 mm by spiral CT scan\n * Evaluable disease includes ascites, pleural effusion, bone metastases, pulmonary lymphangitic spread, and lesions not meeting above criteria as measurable\n\n * Patients with clinically significant ascites or pleural effusions that cannot be controlled by drainage are not eligible\n* Brain metastases allowed if CNS-directed treatment has been given, patient has been off CNS-directed therapy for > 3 months, and CNS disease has been clinically and radiographically stable for at least 8 weeks\n\nPATIENT CHARACTERISTICS:\n\n* Life expectancy > 3 months\n* ECOG performance status 0-2\n* Absolute neutrophil count ≥ 1,500/μL\n* Platelet count ≥ 100,000/μL\n* Creatinine clearance ≥ 60 mL/min\n\n * Patients assigned to group 1 with creatinine clearance 45-80 mL/min must be able to withhold NSAIDS during pemetrexed disodium administration\n* Total bilirubin ≤ 1.5 mg/dL\n* AST and ALT ≤ 3 times upper limit of normal (ULN) OR ≤ 5 times ULN if due to known liver metastases\n* No New York Heart Association class III or IV heart failure\n* No unstable angina\n* No myocardial infarction within the past 6 months\n* No poorly controlled hypertension\n* No prior allergic reaction to any vinca alkaloid\n* No uncontrolled active infection or severe illness\n* Able to receive vitamin B12 and folate supplementation and dexamethasone during chemotherapy\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception during and for 3 months after last dose of chemotherapy\n\nPRIOR CONCURRENT THERAPY:\n\n* At least 4 weeks since prior chemotherapy, investigational agents, or surgery\n* Concurrent cytochrome P450/CYP3A4 inducers or inhibitors are allowed provided patient has been on a stable dose for ≥ 2 weeks prior to study entry\n* No concurrent ketoconazole, itraconazole, ritonavir, amprenavir, or indinavir\n* No concurrent enzyme-inducing antiepileptic drugs (EIAEDs) (e.g., phenytoin, carbamazepine, phenobarbital, primidone, or oxcarbazepine) for patients assigned to group 2"
},
"inclusion_lines": [
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"identified_line": {
"line": "DISEASE CHARACTERISTICS:",
"criterions": [
{
"exact_snippets": "DISEASE CHARACTERISTICS",
"criterion": "disease characteristics",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "DISEASE CHARACTERISTICS",
"criterion": "disease characteristics",
"requirement": {
"requirement_type": "N/A",
"expected_value": "N/A"
}
}
]
}
},
{
"identified_line": {
"line": "* Histologically confirmed solid tumors",
"criterions": [
{
"exact_snippets": "Histologically confirmed solid tumors",
"criterion": "solid tumors",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Histologically confirmed solid tumors",
"criterion": "solid tumors",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
}
]
}
},
{
"identified_line": {
"line": "* Advanced/unresectable or metastatic disease",
"criterions": [
{
"exact_snippets": "Advanced/unresectable",
"criterion": "disease stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"advanced",
"unresectable"
]
}
},
{
"exact_snippets": "metastatic disease",
"criterion": "disease stage",
"requirement": {
"requirement_type": "stage",
"expected_value": "metastatic"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Advanced/unresectable",
"criterion": "disease stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"advanced",
"unresectable"
]
}
}
]
},
{
"exact_snippets": "metastatic disease",
"criterion": "disease stage",
"requirement": {
"requirement_type": "stage",
"expected_value": "metastatic"
}
}
]
}
},
{
"identified_line": {
"line": "* Refractory to standard therapy OR no standard therapy exists",
"criterions": [
{
"exact_snippets": "Refractory to standard therapy",
"criterion": "refractory to standard therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "no standard therapy exists",
"criterion": "standard therapy availability",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Refractory to standard therapy",
"criterion": "refractory to standard therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "no standard therapy exists",
"criterion": "standard therapy availability",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* No lymphoma",
"criterions": [
{
"exact_snippets": "No lymphoma",
"criterion": "lymphoma",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "No lymphoma",
"criterion": "lymphoma",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Measurable disease is defined as at least one target lesion measuring ≥ 20 mm by conventional techniques or ≥ 10 mm by spiral CT scan",
"criterions": [
{
"exact_snippets": "Measurable disease is defined as at least one target lesion measuring ≥ 20 mm by conventional techniques",
"criterion": "target lesion size by conventional techniques",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "mm"
}
}
},
{
"exact_snippets": "Measurable disease is defined as at least one target lesion measuring ... ≥ 10 mm by spiral CT scan",
"criterion": "target lesion size by spiral CT scan",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "mm"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Measurable disease is defined as at least one target lesion measuring ≥ 20 mm by conventional techniques",
"criterion": "target lesion size by conventional techniques",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "mm"
}
}
},
{
"exact_snippets": "Measurable disease is defined as at least one target lesion measuring ... ≥ 10 mm by spiral CT scan",
"criterion": "target lesion size by spiral CT scan",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "mm"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Evaluable disease includes ascites, pleural effusion, bone metastases, pulmonary lymphangitic spread, and lesions not meeting above criteria as measurable",
"criterions": [
{
"exact_snippets": "Evaluable disease includes ascites",
"criterion": "ascites",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evaluable disease includes ... pleural effusion",
"criterion": "pleural effusion",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evaluable disease includes ... bone metastases",
"criterion": "bone metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evaluable disease includes ... pulmonary lymphangitic spread",
"criterion": "pulmonary lymphangitic spread",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evaluable disease includes ... lesions not meeting above criteria as measurable",
"criterion": "lesions not meeting above criteria as measurable",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Evaluable disease includes ascites",
"criterion": "ascites",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evaluable disease includes ... pleural effusion",
"criterion": "pleural effusion",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evaluable disease includes ... bone metastases",
"criterion": "bone metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evaluable disease includes ... pulmonary lymphangitic spread",
"criterion": "pulmonary lymphangitic spread",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evaluable disease includes ... lesions not meeting above criteria as measurable",
"criterion": "lesions not meeting above criteria as measurable",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Patients with clinically significant ascites or pleural effusions that cannot be controlled by drainage are not eligible",
"criterions": [
{
"exact_snippets": "clinically significant ascites",
"criterion": "ascites",
"requirement": {
"requirement_type": "severity",
"expected_value": "clinically significant"
}
},
{
"exact_snippets": "pleural effusions",
"criterion": "pleural effusions",
"requirement": {
"requirement_type": "severity",
"expected_value": "clinically significant"
}
},
{
"exact_snippets": "cannot be controlled by drainage",
"criterion": "control by drainage",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "clinically significant ascites",
"criterion": "ascites",
"requirement": {
"requirement_type": "severity",
"expected_value": "clinically significant"
}
},
{
"exact_snippets": "cannot be controlled by drainage",
"criterion": "control by drainage",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "pleural effusions",
"criterion": "pleural effusions",
"requirement": {
"requirement_type": "severity",
"expected_value": "clinically significant"
}
},
{
"exact_snippets": "cannot be controlled by drainage",
"criterion": "control by drainage",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Brain metastases allowed if CNS-directed treatment has been given, patient has been off CNS-directed therapy for > 3 months, and CNS disease has been clinically and radiographically stable for at least 8 weeks",
"criterions": [
{
"exact_snippets": "Brain metastases allowed",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "CNS-directed treatment has been given",
"criterion": "CNS-directed treatment",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "patient has been off CNS-directed therapy for > 3 months",
"criterion": "CNS-directed therapy",
"requirement": {
"requirement_type": "duration off therapy",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
},
{
"exact_snippets": "CNS disease has been clinically and radiographically stable for at least 8 weeks",
"criterion": "CNS disease stability",
"requirement": {
"requirement_type": "stability duration",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "weeks"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "CNS-directed treatment has been given",
"criterion": "CNS-directed treatment",
"requirement": {
"requirement_type": "completion",
"expected_value": true
}
},
{
"exact_snippets": "patient has been off CNS-directed therapy for > 3 months",
"criterion": "CNS-directed therapy",
"requirement": {
"requirement_type": "duration off therapy",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
},
{
"exact_snippets": "CNS disease has been clinically and radiographically stable for at least 8 weeks",
"criterion": "CNS disease stability",
"requirement": {
"requirement_type": "stability duration",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "weeks"
}
}
}
]
},
{
"exact_snippets": "Brain metastases allowed",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Life expectancy > 3 months",
"criterions": [
{
"exact_snippets": "Life expectancy > 3 months",
"criterion": "life expectancy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Life expectancy > 3 months",
"criterion": "life expectancy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
}
]
}
},
{
"identified_line": {
"line": "* ECOG performance status 0-2",
"criterions": [
{
"exact_snippets": "ECOG performance status 0-2",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ECOG performance status 0-2",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "* Absolute neutrophil count ≥ 1,500/μL",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count ≥ 1,500/μL",
"criterion": "absolute neutrophil count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "μL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Absolute neutrophil count ≥ 1,500/μL",
"criterion": "absolute neutrophil count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "μL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Platelet count ≥ 100,000/μL",
"criterions": [
{
"exact_snippets": "Platelet count ≥ 100,000/μL",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "μL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Platelet count ≥ 100,000/μL",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "μL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Creatinine clearance ≥ 60 mL/min",
"criterions": [
{
"exact_snippets": "Creatinine clearance ≥ 60 mL/min",
"criterion": "creatinine clearance",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "mL/min"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Creatinine clearance ≥ 60 mL/min",
"criterion": "creatinine clearance",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "mL/min"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Patients assigned to group 1 with creatinine clearance 45-80 mL/min must be able to withhold NSAIDS during pemetrexed disodium administration",
"criterions": [
{
"exact_snippets": "Patients assigned to group 1",
"criterion": "group assignment",
"requirement": {
"requirement_type": "group",
"expected_value": "1"
}
},
{
"exact_snippets": "creatinine clearance 45-80 mL/min",
"criterion": "creatinine clearance",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 45,
"unit": "mL/min"
},
{
"operator": "<=",
"value": 80,
"unit": "mL/min"
}
]
}
}
},
{
"exact_snippets": "must be able to withhold NSAIDS during pemetrexed disodium administration",
"criterion": "ability to withhold NSAIDS",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": "Patients assigned to group 1",
"criterion": "group assignment",
"requirement": {
"requirement_type": "group",
"expected_value": "1"
}
},
{
"exact_snippets": "creatinine clearance 45-80 mL/min",
"criterion": "creatinine clearance",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 45,
"unit": "mL/min"
},
{
"operator": "<=",
"value": 80,
"unit": "mL/min"
}
]
}
}
}
]
},
"then_criteria": {
"exact_snippets": "must be able to withhold NSAIDS during pemetrexed disodium administration",
"criterion": "ability to withhold NSAIDS",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* AST and ALT ≤ 3 times upper limit of normal (ULN) OR ≤ 5 times ULN if due to known liver metastases",
"criterions": [
{
"exact_snippets": "AST and ALT ≤ 3 times upper limit of normal (ULN) OR ≤ 5 times ULN if due to known liver metastases",
"criterion": "AST and ALT levels",
"requirement": {
"requirement_type": "level",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 3,
"unit": "times ULN"
}
]
}
}
},
{
"exact_snippets": "AST and ALT ≤ 3 times upper limit of normal (ULN) OR ≤ 5 times ULN if due to known liver metastases",
"criterion": "AST and ALT levels",
"requirement": {
"requirement_type": "level with liver metastases",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "times ULN"
}
]
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "AST and ALT ≤ 3 times upper limit of normal (ULN) OR ≤ 5 times ULN if due to known liver metastases",
"criterion": "AST and ALT levels",
"requirement": {
"requirement_type": "level",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 3,
"unit": "times ULN"
}
]
}
}
},
{
"exact_snippets": "AST and ALT ≤ 3 times upper limit of normal (ULN) OR ≤ 5 times ULN if due to known liver metastases",
"criterion": "AST and ALT levels",
"requirement": {
"requirement_type": "level with liver metastases",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "times ULN"
}
]
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* No New York Heart Association class III or IV heart failure",
"criterions": [
{
"exact_snippets": "No New York Heart Association class III or IV heart failure",
"criterion": "New York Heart Association heart failure class",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": "!=",
"value": 3,
"unit": "class"
}
}
},
{
"exact_snippets": "No New York Heart Association class III or IV heart failure",
"criterion": "New York Heart Association heart failure class",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": "!=",
"value": 4,
"unit": "class"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "No New York Heart Association class III or IV heart failure",
"criterion": "New York Heart Association heart failure class",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": "!=",
"value": 3,
"unit": "class"
}
}
},
{
"exact_snippets": "No New York Heart Association class III or IV heart failure",
"criterion": "New York Heart Association heart failure class",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": "!=",
"value": 4,
"unit": "class"
}
}
}
]
}
},
{
"identified_line": {
"line": "* No myocardial infarction within the past 6 months",
"criterions": [
{
"exact_snippets": "No myocardial infarction within the past 6 months",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "time since last event",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 6,
"unit": "months"
}
]
}
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "No myocardial infarction within the past 6 months",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "time since last event",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 6,
"unit": "months"
}
]
}
}
}
}
},
{
"identified_line": {
"line": "* No prior allergic reaction to any vinca alkaloid",
"criterions": [
{
"exact_snippets": "No prior allergic reaction to any vinca alkaloid",
"criterion": "allergic reaction to vinca alkaloid",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "No prior allergic reaction to any vinca alkaloid",
"criterion": "allergic reaction to vinca alkaloid",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
}
},
{
"identified_line": {
"line": "* No uncontrolled active infection or severe illness",
"criterions": [
{
"exact_snippets": "No uncontrolled active infection",
"criterion": "active infection",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
},
{
"exact_snippets": "No ... severe illness",
"criterion": "severe illness",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "No uncontrolled active infection",
"criterion": "active infection",
"requirement": {
"requirement_type": "control",
"expected_value": false
}
},
{
"exact_snippets": "No ... severe illness",
"criterion": "severe illness",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Able to receive vitamin B12 and folate supplementation and dexamethasone during chemotherapy",
"criterions": [
{
"exact_snippets": "Able to receive vitamin B12",
"criterion": "vitamin B12 supplementation",
"requirement": {
"requirement_type": "ability to receive",
"expected_value": true
}
},
{
"exact_snippets": "Able to receive ... folate supplementation",
"criterion": "folate supplementation",
"requirement": {
"requirement_type": "ability to receive",
"expected_value": true
}
},
{
"exact_snippets": "Able to receive ... dexamethasone during chemotherapy",
"criterion": "dexamethasone during chemotherapy",
"requirement": {
"requirement_type": "ability to receive",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Able to receive vitamin B12",
"criterion": "vitamin B12 supplementation",
"requirement": {
"requirement_type": "ability to receive",
"expected_value": true
}
},
{
"exact_snippets": "Able to receive ... folate supplementation",
"criterion": "folate supplementation",
"requirement": {
"requirement_type": "ability to receive",
"expected_value": true
}
},
{
"exact_snippets": "Able to receive ... dexamethasone during chemotherapy",
"criterion": "dexamethasone during chemotherapy",
"requirement": {
"requirement_type": "ability to receive",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Negative pregnancy test",
"criterions": [
{
"exact_snippets": "Negative pregnancy test",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "test result",
"expected_value": "negative"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Negative pregnancy test",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "test result",
"expected_value": "negative"
}
}
]
}
},
{
"identified_line": {
"line": "* Fertile patients must use effective contraception during and for 3 months after last dose of chemotherapy",
"criterions": [
{
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "must use effective contraception during and for 3 months after last dose of chemotherapy",
"criterion": "contraception use",
"requirement": {
"requirement_type": "duration",
"expected_value": "during and for 3 months after last dose of chemotherapy"
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
"then_criteria": {
"exact_snippets": "must use effective contraception during and for 3 months after last dose of chemotherapy",
"criterion": "contraception use",
"requirement": {
"requirement_type": "duration",
"expected_value": "during and for 3 months after last dose of chemotherapy"
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "PRIOR CONCURRENT THERAPY:",
"criterions": [
{
"exact_snippets": "PRIOR CONCURRENT THERAPY",
"criterion": "prior concurrent therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "PRIOR CONCURRENT THERAPY",
"criterion": "prior concurrent therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* At least 4 weeks since prior chemotherapy, investigational agents, or surgery",
"criterions": [
{
"exact_snippets": "At least 4 weeks since prior chemotherapy",
"criterion": "time since prior chemotherapy",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "At least 4 weeks since prior ... investigational agents",
"criterion": "time since prior investigational agents",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "At least 4 weeks since prior ... surgery",
"criterion": "time since prior surgery",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "At least 4 weeks since prior chemotherapy",
"criterion": "time since prior chemotherapy",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "At least 4 weeks since prior ... investigational agents",
"criterion": "time since prior investigational agents",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "At least 4 weeks since prior ... surgery",
"criterion": "time since prior surgery",
"requirement": {
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Concurrent cytochrome P450/CYP3A4 inducers or inhibitors are allowed provided patient has been on a stable dose for ≥ 2 weeks prior to study entry",
"criterions": [
{
"exact_snippets": "Concurrent cytochrome P450/CYP3A4 inducers or inhibitors are allowed",
"criterion": "cytochrome P450/CYP3A4 inducers or inhibitors",
"requirement": {
"requirement_type": "concurrent use",
"expected_value": true
}
},
{
"exact_snippets": "provided patient has been on a stable dose for ≥ 2 weeks prior to study entry",
"criterion": "stable dose duration",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Concurrent cytochrome P450/CYP3A4 inducers or inhibitors are allowed",
"criterion": "cytochrome P450/CYP3A4 inducers or inhibitors",
"requirement": {
"requirement_type": "concurrent use",
"expected_value": true
}
},
"then_criteria": {
"exact_snippets": "provided patient has been on a stable dose for ≥ 2 weeks prior to study entry",
"criterion": "stable dose duration",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* No concurrent enzyme-inducing antiepileptic drugs (EIAEDs) (e.g., phenytoin, carbamazepine, phenobarbital, primidone, or oxcarbazepine) for patients assigned to group 2",
"criterions": [
{
"exact_snippets": "No concurrent enzyme-inducing antiepileptic drugs (EIAEDs) (e.g., phenytoin, carbamazepine, phenobarbital, primidone, or oxcarbazepine)",
"criterion": "concurrent enzyme-inducing antiepileptic drugs (EIAEDs)",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "for patients assigned to group 2",
"criterion": "patient group assignment",
"requirement": {
"requirement_type": "assignment",
"expected_value": "group 2"
}
},
"then_criteria": {
"exact_snippets": "No concurrent enzyme-inducing antiepileptic drugs (EIAEDs) (e.g., phenytoin, carbamazepine, phenobarbital, primidone, or oxcarbazepine)",
"criterion": "concurrent enzyme-inducing antiepileptic drugs (EIAEDs)",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "PATIENT CHARACTERISTICS:",
"criterions": []
},
"logical_structure": {
"and_criteria": []
}
},
{
"identified_line": {
"line": "* Not pregnant or nursing",
"criterions": [
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
},
{
"exact_snippets": "not ... nursing",
"criterion": "nursing",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
},
{
"exact_snippets": "not ... nursing",
"criterion": "nursing",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* No concurrent ketoconazole, itraconazole, ritonavir, amprenavir, or indinavir",
"criterions": [
{
"exact_snippets": "No concurrent ketoconazole",
"criterion": "concurrent ketoconazole",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No concurrent itraconazole",
"criterion": "concurrent itraconazole",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No concurrent ritonavir",
"criterion": "concurrent ritonavir",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No concurrent amprenavir",
"criterion": "concurrent amprenavir",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No concurrent indinavir",
"criterion": "concurrent indinavir",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "No concurrent ketoconazole",
"criterion": "concurrent ketoconazole",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No concurrent itraconazole",
"criterion": "concurrent itraconazole",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No concurrent ritonavir",
"criterion": "concurrent ritonavir",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No concurrent amprenavir",
"criterion": "concurrent amprenavir",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "No concurrent indinavir",
"criterion": "concurrent indinavir",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"identified_line": {
"line": "* Measurable or evaluable disease",
"criterions": [
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease",
"requirement": {
"requirement_type": "measurability",
"expected_value": [
"measurable",
"evaluable"
]
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease",
"requirement": {
"requirement_type": "measurability",
"expected_value": "measurable"
}
},
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease",
"requirement": {
"requirement_type": "measurability",
"expected_value": "evaluable"
}
}
]
}
},
{
"identified_line": {
"line": "* Total bilirubin ≤ 1.5 mg/dL",
"criterions": [
{
"exact_snippets": "Total bilirubin ≤ 1.5 mg/dL",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dL"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Total bilirubin \u0010.5 mg/dL",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dL"
}
}
}
]
}
},
{
"identified_line": {
"line": "* No unstable angina",
"criterions": [
{
"exact_snippets": "No unstable angina",
"criterion": "unstable angina",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "No unstable angina",
"criterion": "unstable angina",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* No poorly controlled hypertension",
"criterions": [
{
"exact_snippets": "No poorly controlled hypertension",
"criterion": "hypertension",
"requirement": {
"requirement_type": "control",
"expected_value": "not poorly controlled"
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "No poorly controlled hypertension",
"criterion": "hypertension",
"requirement": {
"requirement_type": "control",
"expected_value": "poorly controlled"
}
}
}
}
]
}